Average Co-Inventor Count = 7.74
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (17 from 4,179 patents)
2. Abbvie Inc. (15 from 822 patents)
3. The Sherwin Williams Company (5 from 493 patents)
4. Calgon Corporation (3 from 312 patents)
5. Walter and Eliza Hall Institute of Medical Research (3 from 83 patents)
6. Genentech, Inc. (2 from 3,223 patents)
7. Abbvie Bahamas Limited (6 patents)
40 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
3. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
4. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
5. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
6. 9072748 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
7. 9045444 - Apoptosis promoters
8. 8952157 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
9. 8853209 - 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
10. 8686136 - Apoptosis promoters
11. 8614318 - Apoptosis promoters
12. 8586754 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
13. 8563735 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
14. 8546399 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
15. 8426422 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases